InTouch Health to Appeal Decision in Patent Suit

Santa Barbara, CA, December 6, 2012 – InTouch Health, the leader in acute care telemedicine, today announced a verdict was reached in the Company’s patent infringement suit against VGo Communications, Inc. After a two-week trial the jury found that the VGo robot did not infringe the asserted claims of three InTouch Health patents and that two of the asserted claims were invalid. The Company intends to appeal the decision. 

“We are disappointed with the jury’s verdict, which we believe is erroneous based on what we maintain is strong evidence that the VGo robot infringes our patents,” said Dr. Yulun Wang, Chairman and CEO of InTouch Health. “We also believe that the evidence failed to support the invalidity verdict for two of the asserted claims. We are confident that these decisions will be corrected on appeal.”

“The nature of patent infringement litigation is extremely complex, and the system allows for rulings to be appealed from the district court to the appellate level for review by judges focused on the complexities of patent litigation,” adds Dr. Wang. “We will continue to vigorously defend our patents against infringement by companies attempting to market products in violation of our patent rights.”

InTouch Health leads the acute care telemedicine market with about 700 hospital locations on six continents delivering telemedicine services such as stroke, critical care, cardiology, trauma, pediatrics, neonatology, and surgical/procedure mentoring.  “Our Remote Presence robotic systems are the only FDA cleared class II medical devices on the market authorized for delivering expert, high-acuity telemedicine,” stated Dr. Wang.